Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

4,800

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

October 31, 2023

Study Completion Date

January 31, 2024

Conditions
Gastrointestinal Hemorrhage (Clinically Important, Upper)
Interventions
DRUG

Placebo (0.9% saline)

normal saline

DRUG

Pantoprazole

40 mg powder for injection reconstituted with 0.9% saline

Trial Locations (67)

2050

Sutherland Hospital, Caringbah

Royal North Shore Hospital, Saint Leonards

2148

Blacktown Hospital, Blacktown

2200

Bankstown-Lidcombe Hospital, Bankstown

2217

St George Hospital, Kogarah

2250

Gosford Hospital, Gosford

2500

Wollongong Hospital, Wollongong

2747

Nepean Hospital, Kingswood

3004

Alfred Hospital, Melbourne

3050

Royal Melbourne Hospital, Melbourne

3084

Austin Hospital, Heidelberg

3121

Epworth Hospital, Melbourne

3220

Geelong University Hospital, Geelong

3550

Bendigo Health, Bendigo

4029

Royal Brisbane Womens Hospital, Brisbane

4101

Mater Hospital, South Brisbane

4102

Princess Alexandra Hospital, Woolloongabba

4305

Ipswich Hospital, Ipswich

5000

Royal Adelaide Hospital, Adelaide

11426

King Abdulaziz Medical Center, Riyadh

987400

University of Nebraska - Nebraska Medical Center, Omaha

Unknown

Sociedade Hospitalar Angelina Caron, Campina Grande do Sul

Foothills Hospital, Calgary

Peter Lougheed Hospital, Calgary

Vancouver General Hospital, Vancouver

Vancouver Island Health Authority, Victoria

Brantford General Hospital, Brantford

Hamilton Health Science Center - General Hospital, Hamilton

Hamilton Health Science Center - Juravinski Hospital, Hamilton

Kingston General Hospital, Kingston

London Health Science Center (LHSC) - University Hospital, London

London Health Science Center (LHSC) - Victoria Hospital, London

Ottawa Health Research Institute - OHRI (General and Civic Hospital), Ottawa

Niagara Health Services - St. Catharine's Hospital, St. Catharines

St. Michael's Hospital, Toronto

Centre de recherche de l'Hôtel-Dieu de Lévis, Lévis

Centre Universitaire de Santé McGill / McGill University Health Centre, Montreal

CIUSS du Nord de l'île de Montréal - Hôpital du Sacré-Cœur de Montréal, Montreal

McGill University Health Centre - Montreal General Hospital, Montreal

CHU de Québec-Université Laval - Hôpital Enfant-Jésus, Québec

Institut Universitaire de cardiologie et de pneumologie de Québec Laval, Quebec, Québec

AL-Amiri Hospital, Kuwait City

Maroof International Hospital, Islamabad

35044-220

Beneficência Social Bom Samaritano, Governador Valadares

T6G 2B7

University of Alberta Hospital, Edmonton

V9S 2B7

Nanaimo Regional General Hospital, Nanaimo

V3L 3W7

Royal Columbian Hospital, New Westminster

R2H 2A6

St. Boniface Hospital, Winnipeg

R3A 1R9

Health Science Center Winnipeg, Winnipeg

R3J 3M7

Grace Hospital, Winnipeg

E2L 4L2

Saint John Regional Hospital, Saint John

B3H 2Y9

QEII Health Sciences Centre, Halifax

L6R 3J7

William Osler Hospital, McKenzie Health, Brampton Civic Hospital, Brampton

N1R 3G2

Cambridge Memorial Hospital, Cambridge

L9N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

N2G 1G3

Grand River Hospital, Kitchener

M2K 1E1

North York General Hospital, North York

M4N 3M5

Sunnybrook Health Science Center, Toronto

M5G 1X5

Mount Sinai Hospital, Toronto

M5T 2S8

University Health Network - Toronto Western Hospital, Toronto

M6R 1B5

St. Joseph's Health Centre, Toronto, Toronto

N8W 1L9

Windsor Regional Hospital, Windsor

H1T 2M4

Hôpital Maisonneuve Rosemont, Montreal

H2X 0A9

Center Hospital University Montreal (CHUM), Montreal

J1H 5N4

Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke

S4P 0W5

Regina General Hospital, Regina

SE1 7EH

Guys & St. Thomas Hospital, London

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Canadian Critical Care Trials Group

OTHER

collaborator

Australian and New Zealand Intensive Care Society Clinical Trials Group

NETWORK

collaborator

National Health and Medical Research Council, Australia

OTHER

lead

McMaster University

OTHER

NCT03374800 - Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial | Biotech Hunter | Biotech Hunter